3National committee for clinnical caboratory standards. performance standards for antimcrobial susceptibility testing.Approved standard M100-S9.Pennsylvania:NCCLS.2001.72-75.
5Bustamante CI, Wharton RC, Wade JC. In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolate of Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother,1990,34(9):1814-1815.
6Dudley M N, Blaser J, Gilber D, et al. Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa : effect of simultaneous versus staggered administration in an in vitro model of infection[J]. J Infect Dis, 1991,164(3):499-506.
7Klepser ME, Patel KB, Nicolau DP, et al. Comparison of bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa[J]. Antimicrob Agents Chemother, 19